Panacea Index Logo

Command Palette

Search for a command to run...

Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers.

Methods in molecular biology (Clifton, N.J.)
January 1, 2013
Eliana B Souto et al. (4 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to analyze the use of nanoparticulate carriers for improving the bioavailability and delivery of Coenzyme Q10 and other antioxidants for oral administration.

Results Summary

The study highlights the encapsulation of Coenzyme Q10 in advanced nanoparticulate carriers to enhance its absorption and bioavailability, addressing limitations of conventional antioxidant delivery. It suggests that such delivery systems could improve therapeutic outcomes for various diseases linked to oxidative stress.

Population

Not specified (general focus on human pathologies involving oxidative stress).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (20)
InterventionDirectionEndpointPopulationDosageImpactClaim #
antioxidants
decrease
human pathologies
diabetic patients
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#1
antioxidants
decrease
aging
-
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#2
antioxidants
decrease
cancer diseases
-
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#3
antioxidants
decrease
Parkinson's
-
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#4
antioxidants
decrease
Alzheimer's
-
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#5
antioxidants
decrease
autoimmune disorders
-
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#6
antioxidants
decrease
inflammation
-
-
gained utmost importance because of their potential as prophylactic and therapeutic agents
#7
antioxidants
decrease
absorption profiles
-
limited
have limited absorption profiles, therefore low bioavailability and low concentrations at the target site
#8
antioxidants
decrease
bioavailability
-
low
have limited absorption profiles, therefore low bioavailability and low concentrations at the target site
#9
antioxidants
decrease
concentrations at the target site
-
low
have limited absorption profiles, therefore low bioavailability and low concentrations at the target site
#10
nanoparticulate carriers
increase
encapsulation of drugs and other active ingredients
-
-
successful achievements include the encapsulation
#11
nanoparticulate carriers
increase
encapsulation of coenzyme Q10
-
-
successful achievements include the encapsulation
#12
nanoparticulate carriers
increase
encapsulation of vitamin E
-
-
successful achievements include the encapsulation
#13
nanoparticulate carriers
increase
encapsulation of vitamin A
-
-
successful achievements include the encapsulation
#14
nanoparticulate carriers
increase
encapsulation of resveratrol
-
-
successful achievements include the encapsulation
#15
nanoparticulate carriers
increase
encapsulation of polyphenols
-
-
successful achievements include the encapsulation
#16
nanoparticulate carriers
increase
encapsulation of curcumin
-
-
successful achievements include the encapsulation
#17
nanoparticulate carriers
increase
encapsulation of lycopene
-
-
successful achievements include the encapsulation
#18
nanoparticulate carriers
increase
encapsulation of silymarin
-
-
successful achievements include the encapsulation
#19
nanoparticulate carriers
increase
encapsulation of superoxide dismutase
-
-
successful achievements include the encapsulation
#20
Abstract

Reactive oxygen species (ROS) are known to cause several human pathologies. For this reason, antioxidants have gained utmost importance because of their potential as prophylactic and therapeutic agents in many diseases. Examples of their application include their use in diabetic patients, as aging drugs, in cancer diseases, Parkinson's, Alzheimer's, autoimmune disorders, and also in inflammation. Antioxidants have limited absorption profiles, therefore low bioavailability and low concentrations at the target site. Efforts have been done towards loading antioxidant molecules in advanced nanoparticulate carriers, e.g., liposomes, polymeric nanoparticles, solid lipid nanoparticles, self-emulsifying drug delivery system. Examples of -successful achievements include the encapsulation of drugs and other active ingredients, e.g., coenzyme Q10, vitamin E and vitamin A, resveratrol and polyphenols, curcumin, lycopene, silymarin, and superoxide dismutase. This review focuses on the comprehensive analysis of using nanoparticulate carriers for loading these molecules for oral administration.

Medical Subject Headings (MeSH)
AnimalsAntioxidantsDrug CarriersDrug CompoundingGastrointestinal TractHumansNanoparticlesOxidative StressReactive Oxygen Species
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations26
Citations/Year2.2
Relative Citation Ratio1.01
NIH Percentile50.6%
Research Impact Scores
APT Score0.25
Weight Score0.81
Normalized Score0.67
Related Supplements